369
Participants
Start Date
July 31, 2016
Primary Completion Date
January 31, 2020
Study Completion Date
March 30, 2020
Vadadustat
Oral dose administered once daily for ≥36 weeks. Dose adjustment based on hemoglobin level as defined in the protocol.
Darbepoetin alfa
Subcutaneous or intravenous dose administered for ≥36 weeks. Initial dose based on the current package insert for investigational sites in the United States (US), and the Summary of Product Characteristics for all other investigational sites (non-US) for adult participants with chronic kidney disease not on dialysis. For participants already on Darbepoetin alfa, the initial dosing regimen in the study was based on the prior dosing regimen.
Research Site, Roma
Research Site, Temperley
Research Site, Kyiv
Research Site, Corrientes
Research Site, Córdoba
Research Site, San Luis
Research Site, Junín
Research Site, Seoul
Research Site, Seoul
Research Site, Brovary
Research Site, Zhytomyr
Research Site, Astoria
Research Site, Seongnam-si
Research Site, Genova
Research Site, Cherkassy
Research Site, Rostock
Research Site, Philadelphia
Research Site, Takoma Park
Research Site, Vinnytsia
Research Site, Hampton
Research Site, Lecco
Research Site, Pavia
Research Site, Winston-Salem
Research Site #2, Lawrenceville
Research Site, Statesboro
Research Site, Augusta
Research Site, Columbus
Research Site, Winter Park
Research Site, Coral Springs
Research Site, Miami
Research Site, Coral Gables
Research Site, Miami Beach
Research Site, Miami
Research Site, Lauderdale Lakes
Research Site, Huntsville
Research Site, Nashville
Research Site #1, Chattanooga
Research Site #2, Chattanooga
Research Site, Knoxville
Research Site, Düsseldorf
Research Site, Zapopan
Research Site, Ternopil
Research Site, Busan
Research Site, Roseville
Research Site, Dnipro
Research Site, Siena
Research Site, Mykolaiv
Research Site, Morelia
Research Site, Kharkiv
Research Site, Kansas City
Research Site, Zaporizhzhia
Research Site, San Giovanni Rotondo
Research Site, Ivano-Frankivsk
Research Site, Arlington
Research Site, Houston
Research Site, Houston
Research Site, Villingen-Schwenningen
Research Site, San Antonio
Research Site, El Paso
Research Site, Arvada
Research Site, Westminster
Research Site, Napoli
Research Site, Culiacán
Research Site, Meridian
Research Site, Mesa
Research Site, Albuquerque
Research Site, Uzhhorod
Research Site, Los Angeles
Research Site, Downey
Research Site, Whittier
Research Site, Montebello
Research Site, Glendale
Research Site, Newhall
Research Site #1, Northridge
Research Site #2, Northridge
Research Site, Granada Hills
Research Site, Canyon Country
Research Site, Monterey Park
Research Site, San Dimas
Research Site, La Mesa
Research Site, San Diego
Research Site, Riverside
Research Site, Riverside
Research Site, Anaheim
Research Site, Long Beach
Research Site, Sacramento
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site #2, Kemerovo
Research Site, Krasnoyarsk
Research Site, Stamford
Research Site, San Antonio
Research Site, Bahía Blanca
Research Site, Ciudad Autonoma Buenos Aires
Research Site, Pergamino
Research Site, Salta
Research Site, Fortaleza
Research Site, Belo Horizonte
Research Site, Juiz de Fora
Research Site, Curitiba
Research Site, Maringá
Research Site, Canoas
Research Site, Passo Fundo
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Joinville
Research Site, Santo André
Research Site, São Bernardo do Campo
Research Site, São Paulo
Research Site, Golub-Dobrzyń
Research Site, Lodz
Research Site, Lodz
Research Site, Leiria
Research Site, Loures
Research Site, Chuncheon
Lead Sponsor
Akebia Therapeutics
INDUSTRY